NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 96 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,070 | -72.7% | 11,280 | -33.9% | 0.00% | – |
| Q2 2023 | $44,196 | +34.7% | 17,064 | +112.2% | 0.00% | – |
| Q1 2023 | $32,815 | +553.7% | 8,043 | +704.3% | 0.00% | – |
| Q4 2022 | $5,020 | -73.6% | 1,000 | -31.5% | 0.00% | – |
| Q3 2022 | $19,000 | -20.8% | 1,459 | -21.3% | 0.00% | – |
| Q2 2022 | $24,000 | -87.6% | 1,853 | -85.4% | 0.00% | – |
| Q1 2022 | $193,000 | -42.2% | 12,672 | -32.6% | 0.00% | – |
| Q4 2021 | $334,000 | -13.0% | 18,815 | +2.9% | 0.00% | – |
| Q3 2021 | $384,000 | -55.0% | 18,292 | -57.8% | 0.00% | – |
| Q2 2021 | $854,000 | +85.7% | 43,332 | +174.2% | 0.00% | – |
| Q1 2021 | $460,000 | -57.8% | 15,801 | -56.1% | 0.00% | – |
| Q4 2020 | $1,090,000 | +34.1% | 35,978 | -29.6% | 0.00% | – |
| Q3 2020 | $813,000 | -50.8% | 51,113 | -39.0% | 0.00% | – |
| Q2 2020 | $1,654,000 | +261.1% | 83,792 | +125.7% | 0.00% | – |
| Q1 2020 | $458,000 | -2.3% | 37,131 | +46.5% | 0.00% | – |
| Q4 2019 | $469,000 | +897.9% | 25,337 | +640.8% | 0.00% | – |
| Q3 2019 | $47,000 | +4600.0% | 3,420 | +6740.0% | 0.00% | – |
| Q2 2019 | $1,000 | – | 50 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 15,396,116 | $303,611,000 | 42.97% |
| Ponoi II Management, LLC | 1,298,908 | $25,614,000 | 20.76% |
| Ponoi Management, LLC | 1,298,908 | $25,614,000 | 14.23% |
| Euclidean Capital LLC | 1,493,349 | $29,449,000 | 9.56% |
| RHO CAPITAL PARTNERS INC | 3,766,666 | $74,279,000 | 6.80% |
| Aquilo Capital Management, LLC | 1,194,237 | $23,550,000 | 6.12% |
| Greenspring Associates, LLC | 1,573,357 | $31,027,000 | 2.10% |
| Octagon Capital Advisors LP | 200,000 | $3,944,000 | 0.82% |
| Redmile Group, LLC | 2,792,448 | $55,067,000 | 0.82% |
| BVF INC/IL | 955,000 | $18,833,000 | 0.71% |